Metabolomics in viral hepatitis: Advances and review

J Yang, D Wang, Y Li, H Wang, Q Hu… - Frontiers in Cellular and …, 2023 - frontiersin.org
Viral hepatitis is a major worldwide public health issue, affecting hundreds of millions of
people and causing substantial morbidity and mortality. The majority of the worldwide …

Precision medicine: Determination of ribavirin urinary metabolites in relation to drug adverse effects in HCV patients

O Giampaoli, F Sciubba, E Biliotti, M Spagnoli… - International Journal of …, 2022 - mdpi.com
The most commonly used antiviral treatment against hepatitis C virus is a combination of
direct-acting antivirals (DAAs) and ribavirin (RBV), which leads to a shortened duration of …

[HTML][HTML] Exploration of new therapeutic targets for viral hepatic fibrosis, alcoholic hepatic fibrosis, and non-alcoholic hepatic fibrosis

X Wang, Y Wang, X Li, S Qin, J Xu… - Annals of Translational …, 2022 - ncbi.nlm.nih.gov
Background Hepatic fibrosis is a widespread disease worldwide. Millions of people lose
their lives due to hepatic fibrosis every year. The main causes of hepatic fibrosis include viral …

Screening of common key immune genes and prediction of potential drugs in chronic hepatic injury

T Pang, J Fu, J Li, Y Chen, H He, J Ma, C Liang… - 2024 - researchsquare.com
Studies had revealed that Immune related genes play an important role in Chronic hepatic
injury (CHI), which is the main cause of liver fibrosis. Differentially expressed genes (DEGs) …